NCT06433921salbutamolStudy 2mild asthmaHFA-152aHFA-134aStudy 1cohort 1
…ming potential than HFA-134a. Two phase I studies ( NCT06433908/NCT06433921) compared the pharmacokinetics (PK), pharmacodynamics (PD) and …
Entity family
Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.
This funder is selected. Its supporting articles are shown below.
…ming potential than HFA-134a. Two phase I studies ( NCT06433908/NCT06433921) compared the pharmacokinetics (PK), pharmacodynamics (PD) and …